Quality of Kyeongbo's Bacampicillin bulk approved in Europe.

Published: 2003-10-16 06:58:00

Updated: 2003-10-16 06:58:00

Kyeongbo Pharmaceutical company (President: Kim Young-eun) announced that the bulk of Bacampicillin Hcl, a semi-synthetic penicillin, had obtained its Certificate of Suitability (COS) in Europe, a European drug quality approval, for the first time in Korea.

The COS is one of the most authoritative certificate of drug quality acceptability in Europe, which is a necessary requirement for the...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.